Drugs / ACH-0137171
last change Mar 2007 re-read 3 minutes ago

ACH-0137171

Developed for
hepatitis C virus infection
Investigated by
Achillion, a wholly owned subsidiary of Alexion · Alexion Pharmaceuticals, Inc.

Trials 1

200720082009201020112012201320142015201620172018201920202021202220232024202520262027
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 2 NCT00401947 Nov 2006 → Mar 2007 hepatitis C virus infection Alexion Pharmaceuticals, Inc. Terminated No outcome recorded

Evidence & citations 1 cited value

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as ACH-0137171 ClinicalTrials.gov intervention name — accepted as the source's own label NCT00401947 ↗